Search results for: Consulting Reports
Filter search results
Approaches, Challenges and Successful Stories of Multi-indication Pricing in Europe
28 November 2018
…Economics. RePEc. Towse, A., Cole, A. and Zamora, B., 2018. The Debate on Indication-Based Pricing in the US and Five Major European Countries. OHE Consulting Report. London: Office of Health…
Recommendations for Making Outcome-based Payments a Reality in the NHS: An Application to Cancer Drugs
21 February 2019
…Quality of Life in Long-term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology. OHE Consulting Report. RePEc. Towse, A. and Garrison, L., 2017. Value assessment in precision cancer…
Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England
20 March 2019
…N. and Towse, A., 2016. Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making. OHE Consulting Report. RePEc. Barnsley, P., Towse, A., Karlsberg Schaffer, S. and Sussex, J.,…
OHE Launches Discussion Paper and Consultation Exercise on Indication-based Pricing
10 May 2019
…Pricing in the US and Five Major European Countries . Consulting Report, Office of Health Economics. Neri, M., Towse, A., and Garau, M., 2018. Multi-Indication Pricing (MIP): Practical Solutions and…
Making Outcome-based Payment a Reality in the NHS: Moving to the Next Phase
3 October 2019
…Devlin, N. (2018). Quality of Life in Long-term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology. OHE Consulting Report. RePEc. Towse, A. and Garrison, L., 2017. Value assessment…
Virtual ISPOR European 2020
10 November 2020
…Assessment of Histology Independent Therapies Lotte Steuten, PhD, MSc Vice President and Head of Consulting, Office of Health Economics Moderator Lotte will moderate this Educational Symposium where panellists will provide…
Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Cancer Treatments
8 January 2021
…Henderson N., Steuten L., 2020. Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Medicines. OHE Consulting Report, London: Office of Health Economics. Available at: https://www.ohe.org/publications/bridging-gap-pathways-regulatory-and-health-technology-assessment-histology-independent…
Time to Tackle the Challenges around Combination Therapies for Cancer
29 March 2021
…and Bruce, A., 2021. Why we need a new Outcomes-based Value Attribution Framework for Combination Regimens in Oncology. OHE Consulting Report, London: Office of Health Economics. Available at: https://www.ohe.org/publications/why-we-need-new-outcomes-bas https://www.ohe.org/publications/why-we-need-new-outcomes-based-value-attribution-framework-combination-regimens…
Cost-Effectiveness Thresholds and Expert Elicitation: a Bridge Too Far?
29 April 2021
…to Estimate Cost-effectiveness Thresholds for Decision Making. [OHE Consulting Report] Office of Health Economics. Available at: https://www.ohe.org/publications/shaping-research-agenda-estimate-cost-effectiveness-thresholds-decision-making [Accessed 28 Apr. 2021]. Karlsberg Schaffer, S., Sussex, J., Devlin, N. and Walker,…